sb 203580 has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, M; Li, W; Liu, L; Mao, K; She, H; Wen, Y; Yu, H; Zhang, H; Zou, F | 1 |
| Chen, J; Gui, C; Li, H; Li, W; Mao, K; Ren, Y; Wu, X; Yu, H; Zou, F | 1 |
| Chen, J; Gui, C; Li, W; Mao, K; Ren, Y; Wu, X; Zhao, M; Zou, F | 1 |
| Collins, LM; Long-Smith, CM; Nolan, YM; O'Keeffe, GW; Sullivan, AM; Toulouse, A; Wyatt, SL | 1 |
| Liu, M; Mao, T; Sun, N; Wang, Q; Wei, Z; Zhang, H; Zhang, Y; Zhang, Z | 1 |
| Lu, BX; Luo, YF; Man, RY; Wang, XF; Zeng, QG; Zeng, Y | 1 |
| He, ZY; Luo, XG; Shang, H; Wang, XH; Xie, X | 1 |
| Choi, DY; Han, SB; Hellström, M; Hong, JT; Hwang, CJ; Kim, YE; Oh, KW; Park, EK; Park, MH; Park, PH; Son, DJ | 1 |
| Akaike, A; Izumi, Y; Katsuki, H; Kume, T; Sawada, H; Shimohama, S; Yamamoto, N | 1 |
9 other study(ies) available for sb 203580 and Parkinson Disease
| Article | Year |
|---|---|
p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Chaperone-Mediated Autophagy; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Proteolysis; Pyridines | 2021 |
p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apoptosis; Cell Line, Tumor; Dynamins; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mitochondria; Mitochondrial Dynamics; Mutation; Neurons; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Pyridines; Reactive Oxygen Species; Serine | 2020 |
Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apoptosis; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Enzyme Activation; Humans; Imidazoles; Mice, Transgenic; Mitochondria; Mitophagy; Mutant Proteins; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Phosphoserine; Protein Kinases; Pyridines; Synapses; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2018 |
Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.
Topics: Animals; Cell Survival; Cells, Cultured; Corpus Striatum; Dopaminergic Neurons; Dual Specificity Phosphatase 1; Enzyme Activation; Gene Expression Regulation, Developmental; Imidazoles; Mesencephalon; Nerve Tissue Proteins; Neurites; Neuroprotective Agents; Oxidopamine; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction | 2013 |
[P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Imidazoles; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Pyridines; Substantia Nigra | 2014 |
Induction of GADD45α protects M17 neuroblastoma cells against MPP*.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Anthracenes; Blotting, Western; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Imidazoles; In Situ Nick-End Labeling; Nuclear Proteins; Parkinson Disease; Pyridines; Real-Time Polymerase Chain Reaction; RNA Interference; Tetrazolium Salts; Thiazoles | 2014 |
Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Imidazoles; Immunohistochemistry; Lipopolysaccharides; Male; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Protective Agents; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Rosaniline Dyes | 2017 |
Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
Topics: Animals; Dopaminergic Neurons; Ethanol; Gene Expression Regulation; Humans; Imidazoles; Mice; Mice, Knockout; Mitochondria; Mitophagy; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; PC12 Cells; Pyridines; Rats; Reactive Oxygen Species; Substantia Nigra; Ubiquitin-Protein Ligases | 2017 |
Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Adrenergic Agents; Animals; Cell Nucleus; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Glutathione; Hydrogen Peroxide; Imidazoles; Models, Biological; NF-E2 Transcription Factor; Oxidants; Oxidative Stress; Oxidopamine; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyridines; Rats; Reactive Oxygen Species; Ubiquitin | 2007 |